CLINICAL MANAGEMENT GUIDELINE

Brucellosis

ICD10: Brucellosis, unspecified [A23.9]

Treatment: Antimicrobial agents for pediatric ≤ 8 y/o

-It is a zoonotic infection that's caused by the ingestion of infected animal products; like unpasteurized milk products or aerosol inhalation.

-It can affect multiple organs or tissues.

  • The most common species are B melitensis, B abortus, B suis, and B cabins.
  • It has a high risk of relapse.

This clinical goal is to resolve: 1. Fever or chills. 2. Constitutional symptoms like sweating, lethargy, and weight loss. 3. Arthralgia/Athraitis; difficulty walking (irritable hip) and local inflammatory signs. 4. Hepato/splenomegaly or/and lymphadenopathy. 5. Gastrointestinal manifestations. 6. Other organ-specific manifestations.

Treatments

Level 1 / 1
pharmacological
Trimethoprim
ROUTE
IV/oral
DOSE
5.000 mg
FREQUENCY
BID
pharmacological
Sulfamethoxazole
ROUTE
IV/oral
DOSE
25.000 mg
FREQUENCY
BID
pharmacological
Rifampin
ROUTE
Oral
DOSE
20.000 mg
FREQUENCY
OD

View complete treatment plan

Access complete guideline of Brucellosis now,
with powerful features to assist you for making better clinical management decision

  • Duplicating mechanism of action of effect
  • Weight based dosing
  • Contraindication
  • Renal dosing
  • Interactions to drugs or diseases
  • Hepatic dosing

And more...